Related Experiment Video
Updated: May 26, 2026

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Complications of intracerebral haemorrhage
Joyce S Balami1, Alastair M Buchan
1Acute Stroke Programme, Department of Medicine and Clinical Geratology, Oxford University Hospitals NHS Trust, Oxford, UK.
Insights
Intracerebral haemorrhage (ICH) management is primarily supportive due to limited targeted treatments. Improved surveillance and early complication management are crucial for better outcomes in ICH patients.
Area of Science:
- Neurology
- Neurosurgery
- Critical Care Medicine
Background:
- Intracerebral haemorrhage (ICH) is a severe stroke type, causing significant disability and mortality.
- Current treatments for ICH are limited, unlike those for ischemic stroke.
- ICH management focuses on supportive care and preventing secondary brain injury.
Purpose of the Study:
- To highlight the need for improved surveillance and early management of ICH complications.
- To emphasize the lack of evidence-based targeted treatments for ICH.
- To underscore the importance of reducing adverse effects and improving prognosis in ICH patients.
Main Methods:
- Review of current management strategies for intracerebral haemorrhage.
- Analysis of common complications associated with ICH.
- Discussion of the limitations in evidence-based treatment options.
Main Results:
- ICH is associated with numerous complications, including haematoma expansion, edema, increased intracranial pressure, and hydrocephalus.
- Effective treatments for ICH are scarce, necessitating a focus on supportive care.
- Early detection and management of complications are vital for patient outcomes.
Conclusions:
- Further research is required to develop evidence-based recommendations for ICH management.
- Enhanced surveillance and prompt management of complications can mitigate adverse effects.
- Improved strategies are essential to reduce mortality and disability from ICH.
Abstract:
Intracerebral haemorrhage (ICH) is the most devastating type of stroke and is a leading cause of disability and mortality. By contrast with advances in ischaemic stroke treatment, few evidence-based targeted treatments exist for ICH. Management of ICH is largely supportive, with strategies aimed at the limitation of further brain injury and the prevention of associated complications, which add further detrimental effects to an already lethal disease and jeopardise clinical outcomes. Complications of ICH include haematoma expansion, perihaematomal oedema with increased intracranial pressure, intraventricular extension of haemorrhage with hydrocephalus, seizures, venous thrombotic events, hyperglycaemia, increased blood pressure, fever, and infections. In view of the restricted number of therapeutic options for patients with ICH, improved surveillance is needed for the prevention of these complications, or, when this is not possible, early detection and optimum management, which could be effective in the reduction of adverse effects early in the course of stroke and in the improvement of prognosis. Further studies are needed to enhance the evidence-based recommendations for the management of this important clinical problem.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
